FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against <i>Brucella</i>

Background: Brucellosis poses a significant public health challenge, necessitating effective vaccine development. Current vaccines have limitations such as safety concerns and inadequate mucosal immunity. This study aims to develop an FcRn-targeted mucosal <i>Brucella</i> vaccine by fusi...

詳細記述

書誌詳細

出版年:	Vaccines
主要な著者:	Tingting Tian, Yuejie Zhu, Kaiyu Shang, Huidong Shi, Ruixue Xu, Mingzhe Li, Fuling Pu, Junyu Kuang, Jianbing Ding, Fengbo Zhang
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2025-05-01
主題:	FcRn: neonatal Fc receptor MEV: multi-epitope vaccine mucosal vaccine
オンライン･アクセス:	https://www.mdpi.com/2076-393X/13/6/567